Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[PrenaTest].

Akusherstvo i ginekologiia·2013

Same author

[A comparative study of the prognostic pH values of the fetus in utero, generated by the "quantitative cardiotocography" computer method, and the actual pH values measured immediately after delivery].

Akusherstvo i ginekologiia·2010

Same author

[Case of massive postoperative hemorrhage after hysterectomy and successful application of Novo-Seven].

Akusherstvo i ginekologiia·2006

Same author

[Dermabond--local skin bandage].

Akusherstvo i ginekologiia·2006

Same author

[Klion D - possibilities of prophylaxis and treatment during pregnancy].

Akusherstvo i ginekologiia·2002

Same author

[Intra-arterial chemotherapy in the treatment of liver metastases from colorectal carcinoma].

Khirurgiia·1991

Search research articles

Related Experiment Video

Updated: May 10, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

[Application of Gynofit in obsetrics].

R Velev, M Mircheva

Akusherstvo I Ginekologiia

|July 2, 2013

Summary

Gynofit significantly reduces the second stage of labor by 40% in childbirth. This safe application protects the mother's pelvic floor and perineum with no adverse effects for mother or child.

Area of Science:

Obstetrics and Gynecology
Perinatal Care

Context:

Childbirth involves inherent risks for mothers and newborns.
The second stage of labor is influenced by uterine contractions, elastic forces, and friction.
Evaluating interventions to optimize labor outcomes is crucial.

Purpose:

To assess the impact of Gynofit on labor duration, perineal outcomes, and safety during the second stage of vaginal birth.
To determine the efficacy of Gynofit in reducing labor time and protecting maternal tissues.

Summary:

A four-month study randomized 120 women into four groups to evaluate Gynofit application (vaginal and perineal doses).
Results demonstrated a significant 40% reduction in the second stage of labor duration for both primiparous and multiparous women.
Gynofit application was found to be safe, easy to use, and showed no adverse effects on mothers or newborns.

More Related Videos

Generation and Genetic Manipulation of Human Cervical Organoids

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: May 10, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Generation and Genetic Manipulation of Human Cervical Organoids

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Impact:

Gynofit application during the second stage of labor can shorten delivery time.
The intervention offers protection to the maternal pelvic floor and perineum.
This suggests Gynofit as a potentially beneficial tool in obstetric practice for improving labor efficiency and safety.